S

Suvretta Capital Management LLC

32 employees

Suvretta Capital Management is an investment management company.

Investor insights

Sectors invested in

Biotechnology14
Health Care10
Pharmaceutical7
Biopharma7
Medical5
Therapeutics5
Health Diagnostics3
Life Science3
oncology2
biotechnology2
Oncology2
Radioligand1
Gene therapy1
Patented gene-silencing technology for human disease1
Genetics1
Rare disease1
Finance1
Employee Benefits1
Human Resources1
Software1

Funding rounds participated in

$90M sweet spot round size

Most of their 19 investments are in rounds between $76M and $200M

Investor type

Venture Capital

Basic info

Industry

financial services

Date founded

2011

Investments made

B

Benitec Biopharma raised $3M on August 11, 2023

Investors: Adage Capital Management and Suvretta Capital Management LLC

V

Vicore Pharma AB raised $46M on June 9, 2023

Investors: SEB, OrbiMed Advisors, AP3 - Third Swedish National Pension Fund, HealthCap, Swedbank Robur and Suvretta Capital Management LLC

Z

Zura Bio Limited raised $80M on April 27, 2023

Investors: Great Point Partners and Suvretta Capital Management LLC

P

ProKidney Corp. raised $205M on July 12, 2022

Investors: Suvretta Capital Management LLC

U

Undisclosed raised $76M on December 8, 2021

Investors: Avidity Partners, Lapa Capital LLC, Amedisys, Adage Capital Management and Suvretta Capital Management LLC

F

Freenome raised $300M on December 7, 2021

Investors: Pura Vida Investments, Soleus Capital Management, L.P., Section 32, RA Capital Management, L.P., Sands Capital Management, T. Rowe Price, Ridgeback Capital Management LLC and Suvretta Capital Management LLC

R

Roivant Sciences raised $200M on October 1, 2021

Investors: Patient Square Capital, Dainippon Sumitomo Pharma, Palantir Technologies, Viking Global Investors, Eventide Asset Management, RTW Investments, LP and Suvretta Capital Management LLC

A

Alight Solutions raised $1.6B on July 6, 2021

Investors: Third Point LLC, Cannae Holdings, Inc., Abu Dhabi Investment Authority (ADIA), Chicago Title, Danville CA, Victory Schools, Inc. and New Mountain Capital, LLC and Suvretta Capital Management LLC

P

POINT Biopharma raised $165M on July 1, 2021

Investors: Woodline Partners LP, Farallon Capital Management, RA Capital Management, L.P., Surveyor Capital, Perceptive Advisors and Suvretta Capital Management LLC

A

Arcellx raised $115M on April 13, 2021

Investors: Samsara BioCapital, Soleus Capital Management, L.P., Takeda UK Limited, Novo Holdings, Surveyor Capital, S.R. One Ltd, Sixty Degree Capital and Suvretta Capital Management LLC

FAQ